These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2509074)

  • 1. [Forecasting strategies of hepatitis B vaccination based on decision tree model].
    Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):193-7. PubMed ID: 2509074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
    Zhuang GH; Xu HW
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
    Zhang SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City].
    Liu ZG; Zhao SL; Zhang YX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr; 16(2):81-4. PubMed ID: 7781052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A cost-effectiveness analysis of vaccination against the hepatitis B virus].
    Antoñanzas F; Forcén T; Garuz R
    Med Clin (Barc); 1992 Jun; 99(2):41-6. PubMed ID: 1630178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-benefit analysis for hepatitis A vaccine].
    Chen E; Yao J; Yang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Aug; 20(4):224-7. PubMed ID: 10682501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on serologic markers for screening before hepatitis B vaccination].
    Hui Z; Zhao Z; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):351-3. PubMed ID: 7874705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.